
Celgene - Wikipedia
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.
Bob Hugin - Wikipedia
Robert John Hugin (born July 23, 1954) [1][2] is an American businessman who was formerly the executive chairman of Celgene, a biopharmaceutical company. [3][4] Hugin was the Republican nominee in the 2018 United States Senate election in New Jersey, where he was defeated by incumbent Democratic senator Bob Menendez. [5][6]
Celgene CEO and Key Executive Team | Craft.co
Celgene's Chairman and Chief Executive Officer is Mark J. Alles. Other executives include Zeba M. Khan, Vice President Corporate Responsibility; John Vogler, Director Environment, Health & Safety and 3 others. See the full leadership team at Craft.
BMS reveals its post-Celgene takeover management team
Apr 5, 2025 · On the commercial side, Celgene’s chief financial officer David Elkins will take over from BMS’ Charlie Bancroft, who will see out his time at the company before retirement overseeing the...
Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
Jan 12, 2024 · Mark Alles, who’s spent the better part of the last four decades in biopharma leadership roles, has been named chairman and CEO of TORL BioTherapeutics. He’s replacing Dave Licata, who...
10 Things You Didn’t Know About Celgene CEO Mark Alles
Feb 18, 2019 · Mark Alles is the CEO of the Celgene Corporation. He was appointed to the position in March of 2016. He has an interesting background although he’s not one to step into the spotlight.
Celgene CEO Alles to bag $28M if he departs after BMS merger
Feb 27, 2019 · Alles is set to receive a total of about $27.9 million if he departs after the BMS merger closes, according to a proxy statement filed with the SEC earlier this week. That includes $17...
Celgene names Mark Alles to CEO position, ending internal contest
Jan 15, 2016 · Celgene ($CELG) appointed Chief Operating Officer Mark Alles to be its next CEO, effective March 1, replacing Bob Hugin, who is heading to the executive chairman role.
Rising through the ranks: Interview with Celgene CEO Mark Alles
Apr 5, 2016 · In his new position, Celgene CEO Mark Alles says his military experience gave him the courage to take risks and he is able to reap the rewards.
One-On-One With Celgene's CEO - Life Science Leader
Aug 1, 2016 · New Celgene CEO Mark Alles talks about the daunting task of taking over at this biopharma behemoth and explains the company’s concept of a “leadership incubator.”